/Companies

Tvaster Genkalp

3 known investors

Find your way into Tvaster Genkalp

Sign up to see every warm intro you have to Tvaster Genkalp

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tvaster Genkalp team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tvaster Genkalp is a Chennai-based molecular diagnostics startup that develops liquid biopsy tests using AI-driven epigenetics for non-invasive cancer detection, including its Episcreen Liver test for liver cancer.

Investors · 3

Also in the syndicate · 1

Invigo Softwares

Funding

SEC filings, press & company announcements

$1.3M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Tvaster Genkalp do?
Tvaster Genkalp is a Chennai-based molecular diagnostics startup that develops liquid biopsy tests using AI-driven epigenetics for non-invasive cancer detection, including its Episcreen Liver test for liver cancer.
Who are Tvaster Genkalp's investors?
Tvaster Genkalp's investors include Ideaspring Capital, BIRAC.
How much funding has Tvaster Genkalp raised?
Tvaster Genkalp has disclosed $1.3M raised across 1 of its 2 known rounds.